A comparison between different postoperative treatment modalities of uterine carcinosarcoma (Q81574392)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

title

A comparison between different postoperative treatment modalities of uterine carcinosarcoma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

main subject

uterine carcinosarcoma

1 reference

Joseph Menczer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Tally Levy

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Benjamin Piura

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Angela Chetrit

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Marco Altaras

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Mihai Meirovitz

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Marek Glezerman

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

Ami Fishman

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

publication date

1 April 2005

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

volume

97

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

page(s)

166-170

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

Malignant mixed müllerian tumor of the uterus. Features favoring its origin from a common cell clone and an epithelial-to-mesenchymal transformation mechanism of histogenesis.

10 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Uterine carcinosarcomas (malignant mixed Mullerian tumors) are metaplastic carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Expression of p27 and p53: comparative analysis of uterine carcinosarcoma and endometrial carcinoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Surveillance, epidemiology, and end results analysis of 2677 cases of uterine sarcoma 1989-1999.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Prognostic factors in early-stage uterine sarcoma. A Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Carcinosarcoma of the Uterus: A Clinicopathological Multicenter CTF Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Adjuvant therapy for stage I uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Adjuvant pelvic radiotherapy for uterine carcinosarcoma in a high risk population

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Mixed müllerian tumours of the uterus--prognostic factors: a clinical and histopathologic study of 147 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Radiotherapy in the treatment of uterine sarcomas. A retrospective analysis of 54 cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Results of postoperative radiotherapy in the treatment of sarcoma of the corpus uteri.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

The impact of adjuvant radiotherapy on carcinosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Impact of radiotherapy on local control and survival in uterine sarcomas: a retrospective study from the Grup Oncologic Català-Occità

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Radiotherapy and/or chemotherapy as adjuvant treatment of uterine sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Adjuvant therapy in mixed mullerian tumors of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Uterine sarcomas: a review of the Edinburgh experience from 1974 to 1992.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

The role of whole-pelvic irradiation in the treatment of early-stage uterine carcinosarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Pathologic variables and adjuvant therapy as predictors of recurrence and survival for patients with surgically evaluated carcinosarcoma of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Observations on the use of adjuvant radiation therapy in patients with stage I and II uterine sarcoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Treatment of uterine sarcomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Uterine sarcomas: the Curie Institut experience. Prognosis factors and adjuvant treatments

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

A phase II trial of amonafide in patients with mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Mesna, doxorubicin, ifosfamide, and dacarbazine (MAID) chemotherapy for gynecological sarcomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Phase II evaluation of oral trimetrexate in mixed mesodermal tumors of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Phase II trial of hydroxyurea, dacarbazine (DTIC), and etoposide (VP-16) in mixed mesodermal tumors of the uterus: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Impact on progression-free survival of adjuvant cyclophosphamide, vincristine, doxorubicin (adriamycin), and dacarbazine (CYVADIC) chemotherapy for stage I uterine sarcoma. A prospective trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Efficacy of adjuvant CYVADIC chemotherapy in early-stage uterine sarcomas: results of long-term follow-up

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

A phase II study of etoposide, cisplatin, and doxorubicin chemotherapy in mixed müllerian tumors (MMT) of the uterus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Cisplatin and adriamycin combination chemotherapy for uterine stromal sarcomas and mixed mesodermal tumors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Paclitaxel in the treatment of carcinosarcoma of the uterus: a gynecologic oncology group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Phase II trial of ifosfamide and mesna in mixed mesodermal tumors of the uterus (a Gynecologic Oncology Group study).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Safety and efficacy of adjuvant single-agent ifosfamide in uterine sarcoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

Phase II trial of cisplatin as first-line chemotherapy in patients with advanced or recurrent uterine sarcomas: a Gynecologic Oncology Group study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

A phase III trial of ifosfamide with or without cisplatin in carcinosarcoma of the uterus: A Gynecologic Oncology Group Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2004.12.006

10.1016/J.YGYNO.2004.12.006

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15790453%20AND%20SRC:MED&resulttype=core&format=json

10 January 2020

1 reference